Skip to main content
. 2019 May 17;2(5):e194154. doi: 10.1001/jamanetworkopen.2019.4154

Figure 1. Meta-analysis of the Estimated Hazard of Death Among Patients With Stage II and III Colon Cancer Treated With 6 Months of Adjuvant Chemotherapy Relative to Those Who Received 3 Months of Adjuvant Chemotherapy.

Figure 1.

The edges of the diamond refer to the 95% CI, and the error bars surrounding summary estimates refers to the 95% prediction interval. The size of the individual point estimates corresponds to the model weights. The prediction intervals are as follows: 0.33 to 1.00 for overall survival20,24,26,27,29,30,31,32,33,34,35,36,37,38,41,42,44,45,46 and 0.45 to 1.14 for disease-free survival.1,20,24,32,35,39,41,42,44,45,46,48 CAPOX indicates capecitabine plus oxaliplatin; FOLFOX, leucovorin calcium (folinic acid), fluorouracil, and oxaliplatin; HR, hazard ratio; and NR, not reported.